Global Amyotrophic Lateral Sclerosis Treatment Market 2024-2028

Description

List of Tables

The amyotrophic lateral sclerosis treatment market is forecasted to grow by USD 663.7 mn during 2023-2028, accelerating at a CAGR of 12.79% during the forecast period. The report on the amyotrophic lateral sclerosis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in the incidence and prevalence of amyotrophic lateral sclerosis, a huge unmet need for amyotrophic lateral sclerosis, and high research funding on amyotrophic lateral sclerosis treatment.

Technavio's amyotrophic lateral sclerosis treatment market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	12.48%
CAGR	12.79%
Incremental Value	$663.7mn

By Type

Intravenous
Oral

By Distribution Channel

Hospital pharmacies
Retail pharmacies
Online pharmacies

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in the aging population as one of the prime reasons driving the amyotrophic lateral sclerosis treatment market growth during the next few years. Also, the development of novel drugs for the treatment of amyotrophic lateral sclerosis and rising funding in the healthcare industry will lead to sizable demand in the market.

The report on the amyotrophic lateral sclerosis treatment market covers the following areas:

Amyotrophic lateral sclerosis treatment market sizing
Amyotrophic lateral sclerosis treatment market forecast
Amyotrophic lateral sclerosis treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading amyotrophic lateral sclerosis treatment market vendors that include AB Science SA, Alkem Laboratories Ltd., Apotex Inc., Aquestive Therapeutics Inc., Biogen Inc., Brainstorm Cell Therapeutics Inc., CORESTEM Inc., Cytokinetics Inc., Denali Therapeutics Inc., Dr Reddys Laboratories Ltd., Eledon Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Italfarmaco Holding SPA, Medindia Health, Mitsubishi Chemical Group Corp., Otsuka Holdings Co. Ltd., Revalesio Corp., Sanofi, Sun Pharmaceutical Industries Ltd., and Treeway BV. Also, the amyotrophic lateral sclerosis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72449

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global amyotrophic lateral sclerosis treatment market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global amyotrophic lateral sclerosis treatment market 2018 - 2022 ($ million)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Intravenous - Market size and forecast 2023-2028
Exhibit 34: Chart on Intravenous - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Intravenous - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Intravenous - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Intravenous - Year-over-year growth 2023-2028 (%)
6.4 Oral - Market size and forecast 2023-2028
Exhibit 38: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Hospital pharmacies - Market size and forecast 2023-2028
Exhibit 48: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacies - Market size and forecast 2023-2028
Exhibit 52: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online pharmacies - Market size and forecast 2023-2028
Exhibit 56: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AB Science SA
Exhibit 111: AB Science SA - Overview
Exhibit 112: AB Science SA - Product / Service
Exhibit 113: AB Science SA - Key offerings
12.4 Alkem Laboratories Ltd.
Exhibit 114: Alkem Laboratories Ltd. - Overview
Exhibit 115: Alkem Laboratories Ltd. - Business segments
Exhibit 116: Alkem Laboratories Ltd. - Key news
Exhibit 117: Alkem Laboratories Ltd. - Key offerings
Exhibit 118: Alkem Laboratories Ltd. - Segment focus
12.5 Aquestive Therapeutics Inc.
Exhibit 119: Aquestive Therapeutics Inc. - Overview
Exhibit 120: Aquestive Therapeutics Inc. - Business segments
Exhibit 121: Aquestive Therapeutics Inc. - Key offerings
Exhibit 122: Aquestive Therapeutics Inc. - Segment focus
12.6 Biogen Inc.
Exhibit 123: Biogen Inc. - Overview
Exhibit 124: Biogen Inc. - Product / Service
Exhibit 125: Biogen Inc. - Key offerings
12.7 Brainstorm Cell Therapeutics Inc.
Exhibit 126: Brainstorm Cell Therapeutics Inc. - Overview
Exhibit 127: Brainstorm Cell Therapeutics Inc. - Product / Service
Exhibit 128: Brainstorm Cell Therapeutics Inc. - Key offerings
12.8 Cytokinetics Inc.
Exhibit 129: Cytokinetics Inc. - Overview
Exhibit 130: Cytokinetics Inc. - Business segments
Exhibit 131: Cytokinetics Inc. - Key offerings
Exhibit 132: Cytokinetics Inc. - Segment focus
12.9 Denali Therapeutics Inc.
Exhibit 133: Denali Therapeutics Inc. - Overview
Exhibit 134: Denali Therapeutics Inc. - Product / Service
Exhibit 135: Denali Therapeutics Inc. - Key offerings
12.10 Eledon Pharmaceuticals Inc.
Exhibit 136: Eledon Pharmaceuticals Inc. - Overview
Exhibit 137: Eledon Pharmaceuticals Inc. - Product / Service
Exhibit 138: Eledon Pharmaceuticals Inc. - Key offerings
12.11 Ionis Pharmaceuticals Inc.
Exhibit 139: Ionis Pharmaceuticals Inc. - Overview
Exhibit 140: Ionis Pharmaceuticals Inc. - Business segments
Exhibit 141: Ionis Pharmaceuticals Inc. - Key news
Exhibit 142: Ionis Pharmaceuticals Inc. - Key offerings
Exhibit 143: Ionis Pharmaceuticals Inc. - Segment focus
12.12 Italfarmaco Holding SPA
Exhibit 144: Italfarmaco Holding SPA - Overview
Exhibit 145: Italfarmaco Holding SPA - Product / Service
Exhibit 146: Italfarmaco Holding SPA - Key offerings
12.13 Mitsubishi Chemical Group Corp.
Exhibit 147: Mitsubishi Chemical Group Corp. - Overview
Exhibit 148: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 149: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 150: Mitsubishi Chemical Group Corp. - Segment focus
12.14 Revalesio Corp.
Exhibit 151: Revalesio Corp. - Overview
Exhibit 152: Revalesio Corp. - Product / Service
Exhibit 153: Revalesio Corp. - Key offerings
12.15 Sanofi
Exhibit 154: Sanofi - Overview
Exhibit 155: Sanofi - Business segments
Exhibit 156: Sanofi - Key news
Exhibit 157: Sanofi - Key offerings
Exhibit 158: Sanofi - Segment focus
12.16 Sun Pharmaceutical Industries Ltd.
Exhibit 159: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 160: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 161: Sun Pharmaceutical Industries Ltd. - Key offerings
12.17 Treeway BV
Exhibit 162: Treeway BV - Overview
Exhibit 163: Treeway BV - Product / Service
Exhibit 164: Treeway BV - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations